Psoriasis Clinical Trial

Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis

Summary

4 weeks of adjunctive therapy of Enstilar® QD followed by 12 weeks QOD to patients with 2-10% BSA who are receiving etanercept or adalimumab for at least 24 weeks

View Full Description

Full Description

30 subjects treated with etanercept or adalimumab for at least 24 weeks with a body surface area 2-10% and physician global assessment greater than or equal to 2 will receive Enstilar® once daily for 4 weeks followed by QOD for 12 weeks.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male or female adult ≥ 18 years of age;
Diagnosis of chronic plaque-type
Patient with 2-10% BSA
Physician Global Assessment of 2 or greater
Patient has been treated with etanercept or adalimumab for a minimum of 24 weeks

Exclusion Criteria:

Ë‚2 or >10% BSA
PGA <2
Patient not receiving etanercept or adalimumab, or receiving etanercept or adalimumab <24weeks

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

30

Study ID:

NCT03827876

Recruitment Status:

Unknown status

Sponsor:

Psoriasis Treatment Center of Central New Jersey

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Psoriasis Treatment Center of Central New Jersey
East Windsor New Jersey, 08520, United States More Info
Elise Nelson
Contact
609-443-4500
[email protected]
Jerry Bagel, MD
Principal Investigator
Brian Keegan, MD, PhD
Sub-Investigator
David Nieves, MD
Sub-Investigator
Alexa Hetzel, PA-C
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

30

Study ID:

NCT03827876

Recruitment Status:

Unknown status

Sponsor:


Psoriasis Treatment Center of Central New Jersey

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider